Abstract:AIM: To evaluate the protective effect of NF-kappa B decoy oligodeoxynuleotides (ODNs) on ischemia/reperfusion (I/R) injury in rat liver graft.METHODS: Orthotopic syngeneic rat liver transplantation was performed with 3 h of cold preservation of liver graft in University of Wisconsin solution containing phosphorothioated double-stranded NF-kappa B decoy ODNs or scrambled ODNs. NF-kappa B decoy ODNs or scrambled ODNs were injected intravenously into donor and recipient rats 6 h and 1 h before operation, respectively. Recipients were sacrificed 0h to 16 h after liver graft reperfusion. NF-kappa B activity in the liver graft was analyzed by electrophoretic mobility shift assay (EMSA). Hepatic mRNA expression of TNF-alpha, IFN-gamma and intercellular adhesion molecule-1(ICAM-1) were determined by semiquantitative RT-PCR. Serum levels of TNF-alpha and IFN-gamma were measured by enzyme-linked immunosorbent assays (ELISA). Serum level of alanine transaminase (ALT) was measured using a diagnostic kit. Liver graft myeloperoxidase (MPO) content was assessed.RESULTS: NF-kappa B activation in liver graft was induced in a time -dependent fashion, and NF-kappa B remained activated for 16 h after graft reperfusion. NF-kappa B activation in liver graft was significant at 2 to 8 h and slightly decreased at 16 h after graft reperfusion. Administration of NF-kappa B decoy ODNs significantly suppressed NF-kappa B activation as well as mRNA expression of TNF-alpha, IFN-gamma and ICAM-1 in the liver graft. The hepatic NF-kappa B DNA binding activity [presented as integral optical density (IOD) value] in the NF-kappa B decoy ODNs treatment group rat was significantly lower than that of the I/R group rat (2.16 +/- 0.78 vs 36.78 +/- 6.35 and 3.06 +/- 0.84 vs 47.62 +/- 8.71 for IOD value after 4 h and 8 h of reperfusion, respectively, P < 0.001). The hepatic mRNA expression level of TNF-alpha, IFN-gamma and ICAM-1 [presented as percent of beta-actin mRNA(%)] in the NF-kappa B decoy ODNs treatment group rat was significantly lower than that of the I/R group rat (8.31 +/- 3.48 vs 46.37 +/- 10.65 and 7.46 +/- 3.72 vs 74.82 +/- 12.25 for hepatic TNF-alpha mRNA, 5.58 +/- 2.16 vs 50.46 +/- 9.35 and 6.47 +/- 2.53 vs 69.72 +/- 13.41 for hepatic IFN-gamma mRNA, 6.79 +/- 2.83 vs 46.23 +/- 8.74 and 5.28 +/- 2.46 vs 67.44 +/- 10.12 for hepatic ICAM-1 mRNA expression after 4 hours and 8 h of reperfusion, respectively, P < 0.001). Administration of NF-kappa B decoy ODNs almost completely abolished the increase of serum level of TNF-alpha and IFN-gamma induced by hepatic ischemia/reperfusion, the serum level (pg/ml) of TNF-alpha and IFN-gamma in the NF-kappa B decoy ODNs treatment group rat was significantly lower than that of the I/R group rat (42.7 +/- 13.6 vs 176.7 +/- 15.8 and 48.4 +/- 15.1 vs 216.8 +/- 17.6 for TNF-alpha level, 31.5 +/- 12.1 vs 102.1 +/- 14.5 and 40.2 +/- 13. 5 vs 118.6 +/- 16.7 for IFN-gamma level after 4 hours and 8 h of reperfusion, respectively, P < 0.001). Liver graft neutrophil recruitment indicated by MPO content and hepatocellular injury indicated by serum ALT level were significantly reduced by NF-kappa B decoy ODNs, the hepatic MPO content (A655) and serum ALT level (IU/L) in the NF-kappa B decoy ODNs treatment group rat was significantly lower than that of the I/R group rat (0.17 +/- 0.07 vs 1.12 +/- 0.25 and 0.46 +/- 0.17 vs 1.46 +/- 0.32 for hepatic MPO content, 71.7 +/- 33.2 vs 286.1 +/- 49.6 and 84.3 +/- 39.7 vs 467.8 +/- 62.3 for ALT level after 4 hours and 8 h of reperfusion, respectively, P < 0.001).CONCLUSION: The data suggest that NF-kappa B decoy ODNs protects against I/R injury in liver graft by suppressing NF-kappa B activation and subsequent expression of proinflammatory mediators. (C) 2005 The WJG Press and Elsevier Inc. All rights reserved.

V-Pyrro/No Downregulates Mrna Expression Levels Of Leukotriene C4 Synthase During Hepatic Ischemia Reperfusion Injury In Rats Via Inhibition Of The Nuclear Factor-B Activation Pathway

NO donor V-PYRRO/NO inhibits expression of leukotriene C4 synthase in early stage of hepatic ischemia/reperfusion injury in rats

Sodium Nitroprusside Regulates Mrna Expressions of LTC4 Synthesis Enzymes in Hepatic Ischemia/Reperfusion Injury Rats Via NF-κB Signaling Pathway

Nitric Oxide Donor Regulated mRNA Expressions of LTC4 Synthesis Enzymes in Hepatic Ischemia Reperfusion Injury Rats

Sodium Nitroprusside Decreased Leukotriene C4 Generation by Inhibiting Leukotriene C4 Synthase Expression and Activity in Hepatic Ischemia-Reperfusion Injured Rats.

Increased leukotriene c4 synthesis accompanied enhanced leukotriene c4 synthase expression and activities of ischemia-reperfusion-injured liver in rats.

Effects of antioxidants and NO on TNF-α-induced adhesion molecule expression in human pulmonary microvascular endothelial cells

Effect of Ischemic Preconditioning on P-Selectin Expression in Hepatocytes of Rats with Cirrhotic Ischemia-Reperfusion Injury

The Nitric Oxide Donor, O-2-Vinyl 1-(Pyrrolidin-1-Yl)Diazen-1-Ium-1,2-Diolate (V-Pyrro/No), Protects Against Cadmium-Induced Hepatotoxicity In Mice

The Nitric Oxide Prodrug, V-PYRRO/NO, Protects Against Cadmium Toxicity and Apoptosis at the Cellular Level

Ischemic Preconditioning Decreased Leukotriene C4 Formation by Depressing Leukotriene C4 Synthase Expression and Activity During Hepatic I/R Injury in Rats.

The Protective Effect of PNU-282987, a Selective Α7 Nicotinic Acetylcholine Receptor Agonist, on the Hepatic Ischemia-Reperfusion Injury is Associated with the Inhibition of High-Mobility Group Box 1 Protein Expression and Nuclear Factor Κb Activation in Mice.

Kupffer Cells Protect Liver from Ischemia-Reperfusion Injury by an Inducible Nitric Oxide Synthase-Dependent Mechanism

Nuclear Factor-Kappa B Decoy Oligodeoxynucleotides Attenuates Ischemia/Reperfusion Injury In Rat Liver Graft

Changes of Nitric Oxide and Nitric Oxide Synthase During Hepatic Ischemia/reperfusion of Rat

Effect of Propofol Pretreatment on NF-κB Activity During Hepatic Ischemia-Reperfusion Injury in Rats

New progress in understanding roles of nitric oxide during hepatic ischemia-reperfusion injury

Heme Oxygenase-1 Alleviates Ischemia-Reperfusion Injury by Inhibiting Hepatocyte Pyroptosis after Liver Transplantation in Rats

Role of Nitric Oxide in Toll-like Receptor 2 and 4 Mrna Expression in Liver of Acute Hemorrhagic Necrotizing Pancreatitis Rats

Effect of Nitric Oxide on Toll-Like Receptor 2 and 4 Gene Expression in Rats with Acute Lung Injury Complicated by Acute Hemorrhage Necrotizing Pancreatitis.

Isoflurane Preconditioning at Clinically Relevant Doses Induce Protective Effects of Heme Oxygenase-1 on Hepatic Ischemia Reperfusion in Rats